The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section

Launched by MEDICAL UNIVERSITY OF GRAZ · Jul 26, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating how blood clotting changes immediately after childbirth, whether through a Cesarean section (C-section) or vaginal delivery. The focus is on a condition called hyperfibrinolysis, which can lead to excessive bleeding. Researchers want to understand if these changes are common during and after the delivery of the baby.

The trial is looking for women aged 18 and older who are pregnant with one or more babies and are willing to provide a small blood sample. However, women who are younger than 18, have had a last-minute emergency C-section, have certain blood disorders, or are taking specific medications that affect blood clotting cannot participate. If eligible, participants can expect to provide a 6ml blood sample and contribute to important research that may help improve care for future mothers during delivery.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 18 years and older with a singleton or multiple pregnancy who volunteer for the present study and give one blood sample of 6ml
• Exclusion Criteria:
• • 1. Age \< 18 years
• • 2. Emergency cesarean section
• • 3. History of thrombocytopathy or coagulation disorders
• • 4. Therapy with drugs that influence thrombocyte function and coagulation (ASS less than 5 days ago, clopidogrel, prasugrel, ticagrelor or similar)
• • 5. Lack of consent